Entries of Näher, Helmut on the publication server
![]() | Up a level |
Number of items: 2.
2010
Hauschild, Axel, Weichenthal, Michael, Rass, Knuth, Linse, Ruthild, Berking, Carola, Böttjer, Jörg, Vogt, Thomas, Spieth, Konstanze, Eigentler, Thomas
, Brockmeyer, Norbert H., Stein, Annette, Näher, Helmut, Schadendorf, Dirk, Mohr, Peter, Kaatz, Martin, Tronnier, Michael, Hein, Rüdiger, Schuler, Gerold, Egberts, Friederike and Garbe, Claus
(2010)
Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial.
Journal of Clinical Oncology 28 (5), pp. 841-846.
Fulltext not available.
, Brockmeyer, Norbert H., Stein, Annette, Näher, Helmut, Schadendorf, Dirk, Mohr, Peter, Kaatz, Martin, Tronnier, Michael, Hein, Rüdiger, Schuler, Gerold, Egberts, Friederike and Garbe, Claus
(2010)
Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial.
Journal of Clinical Oncology 28 (5), pp. 841-846.
Fulltext not available.
2009
Hauschild, Axel, Weichenthal, Michael, Rass, Knuth, Linse, Ruthild, Ulrich, Jens, Stadler, Rudolf, Volkenandt, Matthias, Grabbe, Stephan, Proske, Ulrike, Schadendorf, Dirk, Brockmeyer, Norbert, Vogt, Thomas, Rompel, Rainer, Kaufmann, Roland, Kaatz, Martin, Näher, Helmut, Mohr, Peter, Eigentler, Thomas
, Livingstone, Elisabeth and Garbe, Claus
(2009)
Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node–Negative Melanoma.
Journal of Clinical Oncology 27 (21), pp. 3496-3502.
Fulltext not available.
, Livingstone, Elisabeth and Garbe, Claus
(2009)
Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node–Negative Melanoma.
Journal of Clinical Oncology 27 (21), pp. 3496-3502.
Fulltext not available.
